Uranium miners set for melt-up as nuclear energy makes a comeback

Techno-optimists have declared a nuclear renaissance

Companies in the news and how they were assessed

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

UK equities are having their time in the sun. The FTSE 100 recently hit an all-time high of 9,000, driven by a broad recovery in equity prices. To put it another way, the rally wasn’t just driven by a

CITY

Issue of the week: Europe’s capitulation Trump’s ...